Abbott Laboratories (LON:0Q15)

Market Cap	133.88B
Revenue (ttm)	32.94B +5.7%
Net Income	4.85B -51.3%
EPS	2.76 -51.3%
Shares Out	n/a
PE Ratio	27.62
Forward PE	18.57
Dividend	1.80 (1.68%)
Ex-Dividend Date	Jan 15, 2026

Volume	3,852
Average Volume	9,578
Open	108.06
Previous Close	107.00
Day's Range	105.89 - 108.65
52-Week Range	105.95 - 141.41
Beta	0.72
RSI	20.34
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 115,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q15

Financial Performance

In 2025, Abbott Laboratories's revenue was $44.33 billion, an increase of 5.67% compared to the previous year's $41.95 billion. Earnings were $6.52 billion, a decrease of -51.13%.

Financial numbers in USD